Bronchiolitis obliterans after lung transplantation: A review

Chest

Volumn 114, Issue 5, 1998, Pages 1411-1426

  Boehler, Annette ^a,c,d   Kesten, Steven ^b   Weder, Walter ^c   Speich, Rudolf ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d NONE   (Switzerland)

Author keywords

Bronchiolitis obliterans; Chronic allograft rejection; Lung transplantation

Indexed keywords

IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

BRONCHIOLITIS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; INCIDENCE; LUNG TRANSPLANTATION; NONHUMAN; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0031764817     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5.1411     Document Type: Review

References (192)

1. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantation: Fourteenth official report - 1997. J Heart Lung Transplant 1997; 16:691-712
2. Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984; 86:824-829
3. Dauber J. Posttransplant bronchiolitis obliterans syndrome: where have we been and where are we going? [editorial; comment]. Chest 1996; 109:857-859
4. Scott JP, Peters SG, McDougall JC, et al. Posttransplantation physiologic features of the lung and obliterative bronchiolitis. Mayo Clin Proc 1997; 72:170-174
5. Levine SM, Bryan CL. Bronchiolitis obliterans in lung transplant recipients: the "thorn in the side" of lung transplantation [editorial; comment]. Chest 1995; 107:894-897
6. Sundaresan S, Trulock EP, Mohanakumar T, et al. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg 1995; 60:1341-1346
7. Berry GJ, Brunt EM, Chamberlain D, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1990; 9:593-601
8. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15:1-15
9. Cooper J, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts: International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12:713-716
10. Reichenspurner H, Girgis RE, Robbins RC, et al. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1996; 62:1467-1472
11. Cooper JD, Patterson GA, Trulock EP. Results of single and bilateral lung transplantation in 131 consecutive recipients: Washington University Lung Transplant Group. J Thorac Cardiovasc Surg 1994; 107:460-470
12. Valentine VG, Robbins RC, Berry GJ, et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996; 15:371-383
13. Whitehead B, Rees P, Sorensen K, et al. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. J Heart Lung Transplant 1993; 12:903-908
14. Paradis I, Yousem S, Griffith B. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med 1993; 14:751-763
15. Maurer JR. Lung transplantation bronchiolitis obliterans. In: Epler GR, ed. Diseases of the bronchioles. New York: Raven Press, 1994; 275-289
16. Kshettry VR, Kroshus TJ, Savik K, et al. Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients. Chest 1996; 110:704-709
17. Randhawa P, Yousem SA. The pathology of lung transplantation. Pathol Annu 1992; 27:247-279
18. Billingham ME. The pathologic changes in long-term heart and lung transplant survivors. J Heart Lung Transplant 1992; 11:5252-257
19. Chamberlain DW. Lung transplantation pathology: allograft evaluation. In: Patterson GA, Couraud L, eds. Current topics in general thoracic surgery: an international series. Lung transplantation (vol 3). Amsterdam: Elsevier Science, 1995; 307-324
20. Stewart S. Lung transplant pathology. In: Hammond EH, ed. Solid organ transplantation pathology (vol 30). Philadelphia: W.B. Saunders, 1994; 133-158
21. Tazelaar HD, Yousem SA. The pathology of combined heart-lung transplantation: an autopsy study. Hum Pathol 1988; 19:1403-1416
22. Yousem SA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol 1993; 17:491-496
23. Kelly K, Hertz MI. Obliterative bronchiolitis. In: Maurer JR, ed. Surgical approaches to end-stage disease: lung transplantation and volume reduction (vol 18). Clin Chest Med Philadelphia: W.B. Saunders, 1997; 319-338
24. Yousem SA, Paradis IL, Dauber JH, et al. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation 1989; 47:564-569
25. Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312:152-158
26. Milne DS, Gascoigne AD, Ashcroft T, et al. Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis. Transplantation 1994; 57:1757-1762
27. Siddiqui MT, Garrity ER, Husain AN. Bronchiolitis obliterans organizing pneumonia-like reactions: a nonspecific response or an atypical form of rejection or infection in lung allograft recipients? Hum Pathol 1996; 27:714-719
28. Chaparro C, Chamberlain D, Maurer J, et al. Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients. Chest 1996; 110:1150-1154
29. Milne DS, Gascoigne AD, Wilkes J, et al. MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients. Transplantation 1994; 57:1762-1766
30. Duquesnoy RJ, Trager JD, Zeevi A. Propagation and characterization of lymphocytes from transplant biopsies. Crit Rev Immunol 1991; 10:455-480
31. McSherry C, Hertz MI, Jackson AM, et al. Allogeneic microchimerism and donor antigen-specific hyporeactivity in lung transplant recipients. Clin Transplant 1995; 9:442-449
32. Zeevi A, Rabinowich H, Yousem SA, et al. Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans. Transplant Proc 1991; 23:1128-1129
33. Hasegawa S, Ockner DM, Ritter JH, et al. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection. Arch Pathol Lab Med 1995; 119:432-439
34. Yousem SA, Martin T, Paradis IL, et al. Can immunohistological analysis of transbronchial biopsy specimens predict responder status in early acute rejection of lung allografts? Hum Pathol 1994; 25:525-529
35. Demetris AJ, Qian SG, Sun H, et al. Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol 1990; 14:49-63
36. Mihatsch MJ, Ryffel B, Gudat F. Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy. Transplant Proc 1993; 25:2031-2037
37. Johnson DE, Alderman EL, Schroeder JS, et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991; 17:449-457
38. Sharples LD, Tamm M, McNeil K, et al. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: early risk factors. Transplantation 1996; 61:560-566
39. Bando K, Paradis IL, Similo S, et al. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg 1995; 110:4-13
40. Keller CA, Cagle PT, Brown RW, et al. Bronchiolitis oliterians in recipients of single, double, and heart-lung transplantation. Chest 1995; 107:973-980
41. Scott JP, Higenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51:813-817
42. Yousem SA, Dauber JA, Keenan R, et al. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991; 52:306-309
43. Fellstrom B. Immune injury: is it all there is to chronic graft rejection [editorial]? Nephrol Dial Transplant 1995; 10:149-151
44. Paul LC. Functional and histologic characteristics of chronic renal allograft rejection. Clin Transplant 1994; 8:319-323
45. Hayry P. Molecular pathology of acute and chronic rejection. Transplant Proc 1994; 26:3280-3284
46. Duncan SR, Valentine V, Roglic M, et al. T cell receptor biases and clonal proliferations among lung transplant recipients with obliteraive bronchiolitis. J Clin Invest 1996; 97:2642-2650
47. Yousem SA, Isaacs A. Pulmonary neuroendocrine cells in the airways of lung allografts. Transplantation 1995; 59: 1070-1073
48. Hayry P, Alatalo S, Myllarniemi M, et al. Cellular and molecular biology of chronic rejection. Transplant Proc 1995; 27:71-74
49. Shreeniwas R, Schulman LL, Narasimhan M, et al. Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection. Chest 1996; 110:1143-1149
50. Magnan A, Mege JL, Escallier JC, et al. Balance between alveolar macrophage IL-6 and TGF-beta in lung-tranplant recipients: Marseille and Montreal Lung Transplantation Group. Am J Respir Crit Care Med 1996; 153:1431-1436
51. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59:313-318
52. Halloran PF, Homik J, Goes N, et al. The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997; 29: 79-81
53. Paul LC, Benediktsson H. Chronic transplant rejection: magnitude of the problem and pathogenetic mechanisms. Transplant Rev 1993; 7:96-113
54. Siddiqui MT, Garrity ER, Martinez R, et al. Bronchiolar basement membrane changes associated with bronchiolitis obliterans in lung allografts study: a retrospective study of serial transbronchial biopsies with immunohistochemistry. Mod Pathol 1996; 9:320-328
55. Yousem SA, Suncan SR, Ohori NP, et al. Architectural remodeling of lung allografts in acute and chronic rejection. Arch Pathol Lab Med 1992; 116:1175-1180
56. Polonovsky V, Bitterman PB. Regulation of cell population size. In: Crystal RG, West JB, Weibel ER, Barnes PJ, eds. The lung (vol 1). Philadelphia: Lippincott-Raven, 1997; 133-153
57. McDowell EM, Keenan KP, Huang M. Restoration of mucociliary tracheal epithelium following deprivation of vitamin A: a quantitative morpholigic study. Virchows Arch B Cell Pathol 1984; 45:221-240
58. 2. Am J Pathol 1986; 123:126-133
59. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381:434-438
60. Hertz MI, Jessurun J, King MB, et al. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993; 142:1945-1951
61. Huang XH, Reichenspurner H, Shorthouse R, et al. Heterotopic tracheal allograft transplantation: a new model to study the molecular events causing obliterative airway disease in rats. J Heart Lung Transplant 1995; 14:549
62. Boehler A, Chamberlain D, Kesten S, et al. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation 1997; 64:311-317
63. Koskinen PK, Kallio EA, Krebs R, et al. A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts. Am J Respir Crit Care Med 1997; 155:303-312
64. King MB, Jessurun J, Savik SK, et al. Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation 1997; 63:528-532
65. Tazelaar HD, Prop J, Nieuwenhuis P, et al. Airway pathology in the transplanted rat lung. Transplantation 1988; 45:864-869
66. Tullius SG, Hancock WW, Heemann U, et al. Reversibility of chronic renal allograft rejection: critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation 1994; 58:93-99
67. Izutani H, Miyagawa S, Shirakura R, et al. Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction: histopathological analysis using a retransplantation model. Transplantation 1995; 60:1073-1079
68. Brazelton TR, Adams B, Morris RE, Removal of alloimmune injury fails to prevent subsequent progression of obliterative airway disease in rat tracheal allografts [abstract]. J Heart Lung Transplant 1997; 16:A69
69. Tullius SG, Heemann U, Hancock WW, et al. Long-term kidney isografts develop functional and morphologic changes that mimic those of chronic allograft rejection. Ann Surg 1994; 220:425-432
70. Tullius SG, Heemann UV, Azuma H, et al. Characteristic signs of chronic allograft rejection can be observed in mechanically manipulated naive rat kidneys over the long term. Transplant Proc 1995; 27:2131-2132
71. Goes N, Urmson J, Ramassar V, et al. Ischemic acute tubular necrosis induces an extensive local cytokine response: evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59:565-572
72. al-Dossari GA, Jessurun J, Bolman RM III, et al. Pathogenesis of obliterative bronchiolitis: possible roles of platelet-derived growth factor and basic fibroblast growth factor. Transplantation 1995; 59:143-145
73. Konichezky S, Schattner A, Ezri T, et al. Thionyl-chloride-induced lung injury and bronchiolitis obliterans. Chest 1993; 104:971-973
74. Matarese SL, Matthews JI. Zinc chloride (smoke bomb) inhalational lung injury. Chest 1986; 89:308-309
75. Tasaka S, Kanazawa M, Mori M, et al. Long-term course of bronchiectasis and bronchiolitis obliterans as late complication of smoke inhalation. Respiration 1995; 62:40-42
76. Sung RY, Chan RC, Tam JS, et al. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants. Epidemiol Infect 1992; 108:147-154
77. Wiebicke W, Seidenberg J. Obliterierende Bronchiolitis nach Masern. Pneumologie 1990; 44:1220-1222
78. Prabhu MB, Barber D, Cockcroft DW. Bronchiolitis obliterans and Mycoplasma pneumonia. Respir Med 1991; 85: 535-537
79. Coultas DB, Samet JM, Butler C. Bronchiolitis obliterans due to Mycoplasma pneumoniae. West J Med 1986; 144: 471-474
80. Boehler A, Vogt P, Speich R, et al. Bronchiolitis obliterans in a patient with localized scleroderma treated with d-penicillamine. Eur Respir J 1996; 9:1317-1319
81. Demaziere A, Maugars Y, Chollet S, et al. Non-fatal bronchiolitis obliterans possibly associated with tiopronin: a case report with long-term follow-up [letter]. Br J Rheumatol 1993; 32:172-174
82. Elliott CG, Colby TV, Kelly TM, et al. Charcoal lung: bronchiolitis obliterans after aspiration of activated charcoal. Chest 1989; 96:672-674
83. Kaufman J, Komorowski R. Bronchiolitis obliterans: a new clinical-pathologic complication of irradiation pneumonias. Chest 1990; 97:1243-1244
84. Spain BA, Cummings O, Garcia JG. Bronchiolitis obliterans in an animal feed worker. Am J Ind Med 1995; 28:437-443
85. Kargi HA, Kuhn C. Bronchiolitis obliterans: unilateral fibrous obliteration of the lumen of bronchi with atelectasis. Chest 1988; 93:1107-1108
86. Foo SS, Weisbrod GL, Herman SJ, et al. Wegener granulomatosis presenting on CT with atypical bronchovasocentric distribution. J Comput Assist Tomogr 1990; 14:1004-1006
87. Peckholz I, Penther M, Mergner S. Zur Kenntnis der Bronchiolitis obliterans connata (Bericht über das Krankheitsbild bei 2 Spätaborten). Zentralbl Allg Pathol 1986; 132:329-333
88. Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine 1993; 72:151-183
89. Veloso FT, Rodrigues H, Aguiar MM. Bronchiolitis obliterans in ulcerative colitis. J Clin Gastroenterol 1994; 19:339-341
90. Lai RS, Chiang AA, Wu MT, et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 1996; 348: 83-85
91. Chang H, Wang JS, Tseng HH, et al. Histopathological study of Sauropus androgynus-associated constrictive bronchiolitis obliterans. Am J Surg Pathol 1997; 21:35-42
92. Sharples LD, Scott JP, Dennis C, et al. Risk factors for survival following combined heart-lung transplantation: the first 100 patients. Transplantation 1994; 57:218-223
93. Clelland C, Higenbottam T, Otulana B, et al. Histologic prognostic indicators for the lung allografts of heart-lung transplants. J Heart Transplant 1990; 9:177-185
94. Scott JP, Fradet G, Smyth RL, et al. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant 1991: 10:626-636
95. Duquesnoy R, Zeevi A. Immunology monitoring of lung transplant patients by bronchoalveolar analysis. Transplant Rev 1992; 6:218-230
96. McSherry C, Jackson A, Hertz MI, et al. Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. Transplantation 1996; 62:1811-1818
97. El-Gamel A, Yonan NA, Simm F, et al. Transforming growth factor-beta (TGF-β) and obliterative bronchiolitis (OB) following pulmonary transplantation [abstract]. J Heart Lung Transplant 1997; 16:A68
98. De Hoyos A, Chamberlain D, Schvartzman R, et al. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest 1993; 103:1813-1818
99. Hutter JA, Stewart S, Higenbottam T, et al. Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy. J Heart Transplant 1988; 7:440-444
100. Boehler A, Vogt P, Zollinger A, et al. Prospective study of the value of regular transbronchial lung biopsy in the management of lung transplant recipients. Eur Respir J 1996; 9:658-662
101. Yousem SA. Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients. Hum Pathol 1996; 27:269-273
102. Itescu S, Weinberg AD, Burke EM, et al. Risk factors for early onset obliterative bronchiolitis after lung transplantation: influence of donor HLA-DR4 type [abstract]. J Heart Lung Transplant 1997; 16:A69
103. Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51:433-438
104. Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis 1993; 147:1017-1023
105. Humbert M, Emilie D. Infection à cytomégalovirus et rejet d'alolgreffe. Rev Mal Respir 1996; 13(suppl):S85-S91
106. Bando K, Paradis IL, Komatsu K, et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc Surg 1995; 109:49-57
107. Soghikian MV, Valentine VG, Berry GJ, et al. Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. J Heart Lung Transplant 1996; 15:881-887
108. Duncan SR, Grgurich WF, Iacono AT, et al. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 1994; 150:146-152
109. Hohlfeld J, Niedermeyer J, Hamm H, et al. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 1996; 15:888-894
110. Sundset A, Tadjkarimi S, Khaghani A, et al. Human en bloc double-lung transplantation: bronchial artery revascularization improves airway perfusion. Ann Thorac Surg 1997; 63:790-795
111. Pettersson G, Norgaard MA, Arendrup H, et al. Direct bronchial artery revascularization and en bloc double lung transplantation: surgical techniques and early outcome. J Heart Lung Transplant 1997; 16:320-333
112. Velly JF, Dromer C, Baudet E, et al. Technique of en bloc double-lung transplantation with bronchial revascularization. In: Patterson GA, Couraud L, eds. Lung transplantation (vol 3). Amsterdam: Elsevier, 1995; 217-234
113. Baudet EM, Dromer C, Dubrez J, et al. Intermediate-term results after en bloc double-lung transplantation with bronchial arterial revascularization. Bordeaux Lung and Heart-Lung Transplant Group. J Thorac Cardivasc Surg 1996; 112:1292-1299
114. Weinberg D, Tung TC, Smith CM, et al. Donor and recipient mismatches at HLA-DR and HLA-B loci are risk factors for high grade cellular rejections in lung transplantation [abstract]. J Heart Lung Transplant 1997; 16:A68
115. Manez R, White LT, Linden P, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993; 55:1067-1071
116. O'Grady JG, Alexander GJ, Sutherland S, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988; 2:302-305
117. Reid KR, McKenzie FN, Menkis AH, et al. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet 1990; 336:206-208
118. Kirk AJ, Colquhoun IW, Corris PA, et al. Impaired gastrointestinal motility in pulmonary transplantation [letter]. Lancet 1990; 336:752
119. Au J, Hawkins T, Venables C, et al. Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg 1993; 55:94-97
120. Rinaldi M, Martinelli L, Volpato G, et al. Gastro-esophageal reflux as cause of obliterative bronchiolitis: a case report. Transplant Proc 1995; 27:2006-2007
121. Herve P, Silbert D, Cerrina J, et al. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. Chest 1993; 103:59-63
122. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997; 155:789-818
123. Morrish WF, Herman SJ, Weisbrod GL, et al. Bronchiolitis obliterans after lung transplantation: findings at chest radiography and high-resolution CT. The Toronto Lung Transplant Group. Radiology 1991; 179:487-490
124. Levine SM, Anzueto A, Peters JI, et al. Medium-term functional results of single-lung transplantation for endstage obstructive lung disease. Am J Respir Crit Care Med 1994; 150:398-402
125. Becker FS, Martinez FJ, Brunsting LA, et al. Limitations of spirometry in detecting rejection after single-lung transplantation. Am J Respir Crit Care Med 1994; 150:159-166
126. Patterson GM, Wilson S, Whang JL, et al. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 1996; 15:175-181
127. Bassiri AG, Girgis RE, Doyle RL, et al. Detection of small airway dysfunction using specific airway conductance. Chest 1997; 111:1533-1535
128. Ikonen T, Harjula AL, Kinnula VL, et al. Assessment of forced expiratory volume in one second-fraction of the engrafted lung with 133-Xe radiospirometry improves the diagnosis of bronchiolitis obliterans syndrome in single lung transplant recipients. J Heart Lung Transplant 1995; 14: 244-250
129. Ross DJ, Belman MJ, Mohsenifar Z, et al. Obstructive flow-volume loop contours after single lung transplantation. J Heart Lung Transplant 1994; 13:508-513
130. Rajagopalan N, Maurer J, Kesten S. Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients. Chest 1996; 109:405-407
131. Burke CM, Theodore J, Baldwin JC, et al. Twenty-eight cases of human heart-lung transplantation. Lancet 1986; 1:517-519
132. Skeens JL, Fuhrman CR, Yousem SA. Bronchiolitis obliterans in heart-lung transplantation patients: radiologic findings in 11 patients. AJR Am J Roentgenol 1989; 153:253-256
133. Lynch DA. Imaging of small airways diseases. Clin Chest Med 1993; 14:623-34
134. Loubeyre P, Revel D, Delignette A, et al. Bronchiectasis detected with thin-section CT as a predictor of chronic lung allograft rejection. Radiology 1995; 194:213-216
135. Muller NL, Miller RR. Diseases of the bronchioles: CT and histopathologic findings. Radiology 1995; 196:3-12
136. Garg K, Lynch DA, Newell JD, et al. Proliferative and constrictive bronchiolitis: classification and radiologic features. AJR Am J Roentgenol 1994; 162:803-808
137. Padley SP, Adler BD, Hansell DM, et al. Bronchiolitis obliterans: high resolution CT findings and correlation with pulmonary function tests. Clin Radiol 1993; 47:236-240
138. Leung AN, Fisher KL, Valentine V, et al. Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT. Chest 1998; 113:365-370
139. Engeler CE. Heart-lung and lung transplantation. Radiol Clin North Am 1995; 33:559-580
140. Herman SJ. Radiologic assessment after lung transplantation. Radiol Clin North Am 1994; 32:663-678
141. Eber CD, Stark P, Bertozzi P. Bronchiolitis obliterans on high-resolution CT: a pattern of mosaic oligemia. J Comput Assist Tomogr 1993; 17:853-856
142. Stern EJ, Frank MS. Small-airway diseases of the lungs: findings at expiratory CT. AJR Am J Roentgenol 1994; 163:37-41
143. Ikonen T, Kivisaari L, Harjula AL, et al. Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome. J Heart Lung Transplant 1996; 15:587-595
144. Mannes GP, de Boer WJ, Meuzelaar JJ, et al. Ventilation-perfusion inequalities in a patient with obliterative bronchiolitis after single-lung transplantation for primary pulmonary hypertension [letter]. Chest 1993; 103:1311
145. Halvorsen RA Jr, DuCret RP, Kuni CC, et al. Obliterative bronchiolitis following lung transplantation: diagnostic utility of aerosol ventilation lung scanning and high resolution CT. Clin Nucl Med 1991; 16:256-258
146. Levine SM, Jenkinson SG, Bryan CL, et al. Ventilation-perfusion inequalities during graft rejection in patients undergoing single lung transplantation for primary pulmonary hypertension. Chest 1992; 101:401-405
147. DiGiovine B, Lynch JP III, Martinez FJ, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 1996; 157:4194-4202
148. Higenbottam T, Stewart S, Penketh A, et al. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46:532-539
149. Chamberlain D, Maurer J, Chaparro C, et al. Evaluation of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 1994; 13:963-971
150. Ladowski JS, Hayhurst TE, Scheeringa RH, et al. Obliterative bronchiolitis following single-lung transplantation: diagnosis by spirometry and transbronchial biopsy. Transplantation 1993; 55:207-209
151. Kramer MR, Stoehr C, Whang JL, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993; 12:675-681
152. Cagle PT, Brown RW, Frost A, et al. Diagnosis of chronic lung transplant rejection by transbronchial biopsy. Mod Pathol 1995; 8:137-142
153. Pomerance A, Madden B, Burke MM, et al. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J Heart Lung Transplant 1995; 14:761-773
154. Nathan SD, Ross DJ, Belman MJ, et al. Bronchiolitis obliterans in single-lung transplant recipients. Chest 1995; 107:967-972
155. Reichenspurner H, Girgis RE, Robbins RC, et al. Obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1995; 60:1845-1853
156. Snell GI, Esmore DS, Williams TJ. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 1996; 109:874-878
157. Kesten S, Rajagopalan N, Maurer J. Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 1996; 61:427-430
158. Dusmet M, Maurer J, Winton J, et al. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 1996; 15: 948-954
159. Reichenspurner H, Meiser BM, Kur F, et al. First experience with FK 506 for treatment of chronic pulmonary rejection. Transplant Proc 1995; 27:2009
160. Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995; 60:580-584
161. Kesten S, Chaparro C, Scavuzzo M, et al. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. J Heart Lung Transplant 1997; 16:905-912
162. Halloran P, Mathew T, Tomlanovich S, et al. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 1997; 63:39-47
163. Hayry P. Immunosuppressive drugs. In: Wood K, ed. The handbook of transplant immunology. MedSci Publications 1995; 152-156
164. Raisanen-Sokolowski A, Aho P, Myllarniemi M, et al. Inhibition of early chronic rejection in rat aortic allografts by mycophenolate mofetil (RS61443). Transplant Proc 1995; 27:435
165. Raisanen-Sokolowski A, Vuoristo P, Myllarniemi M, et al. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. Transpl Immunol 1995; 3:342-351
166. O'Hair DP, Umana JP, McGregor C, et al. Lung transplantation using mycophenolate mofetil [abstract]. J Heart Lung Transplant 1997; 16:A75
167. Zuckermann A, Birsan T, Taghavi S, et al. Comparison between mycophenolate mofetil and azathioprine based immunosuppressions in clinical lung transplantation [abstract]. J Heart Lung Transplant 1997; 16:A76
168. ®) versus azathioprine (Aza) immunosuppressive regimens after lung transplantation: preliminary experience [abstract]. J Heart Lung Transplant 1997; 16:A76
169. Speich R, Boehler A, Thurnheer R, et al. Salvage therapy with mycophenolate mofetil for lung transplant bronchiolitis obliterans: importance of dosage. Transplantation 1997; 64:533-535
170. Gruber SA, Hughes SE, Xiao S, et al. Pharmacokinetics and pharmacodynamics of 15-deoxyspergualin in a canine renal allograft model of local immunosuppression. J Surg Res 1997; 71:137-144
171. Blot F, Tavakoli R, Sellam S, et al. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study. J Heart Lung Transplant 1995; 14:1162-1172
172. Wang X, Alfrey EJ, Posselt A, et al. Intraportal delivery of immunosuppression to intrahepatic islet allograft recipients. Transpl Int 1995; 8:268-272
173. Ko S, Nakajima Y, Kanehiro H, et al. Immunologic aspects of local immunosuppression in canine liver transplantation. Transplant Proc 1994; 26:849-850
174. Takao M, Katayama Y, Onoda K, et al. Significance of bronchial mucosal blood flow for the monitoring of acute rejection in lung transplantation. J Heart Lung Transplant 1991; 10:956-966
175. Novick RJ, Ahmad D, Menkis AH, et al. The importance of acquired diffuse bronchomalacia in heart-lung transplant recipients with obliterative bronchiolitis. J Thorac Cardiovasc Surg 1991; 101:643-648
176. Keenan RJ, Zeevi A, Iacono AT, et al. Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics. Surgery 1995; 118:385-391
177. Iacono AT, Keenan RJ, Duncan SR, et al. Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med 1996; 153:1451-1455
178. Takao M, Higenbottam TW, Audley T, et al. Effects of inhaled nebulized steroids (budesonide) on acute and chronic lung function in heart-lung transplant patients. Transplant Proc 1995; 27:1284-1285
179. Speich R, Boehler A, Russi EW, et al. A case report of a double-blind, randomized trial of inhaled steroids in a patient with lung transplant bronchiolitis obliterans. Respiration 1997; 64:375-380
180. Slovis BS, Loyd JE, King LE Jr. Photopheresis for chronic rejection of lung allografts [letter]. N Engl J Med 1995; 332:962
181. Nepomuceno DJ, Simpson KP, McCabe MA, et al. Plasmapheresis in the treatment of chronic rejection/BOS following lung transplantation [abstract]. Am J Respir Crit Care Med 1997; 155:A389
182. Afolabi OA, Parry G, Healy MD, et al. The role of total lymphoid irradiation (TLI) in the treatment of obliterative bronchiolitis: 2 years on [abstract]. J Heart Lung Transplant 1996; 15:5102
183. Zeevi A, Pham S, Pavlick M, et al. Donor-specific bone marrow infusion in lung transplant recipients: the impact on immune modulation and delayed graft rejection [abstract]. J Heart Lung Transplant 1997; 16:A69
184. Khavari PA, Edelson RL, Lider O, et al. Specific vaccination against photoinactivated cloned T cells [abstract]. Clin Res 1988; 36:662A
185. Achkar A, Laaban JP, Andreu G, et al. Extracorporeal photochemotherapy (ECP) for bronchiolitis obliterans (BO) after heart-lung (HTLx) and lung transplantation (LTx) [abstract]. Am J Respir Crit Care Med 1997; 155:A277
186. Karamachandani K, McCabe M, Simpson KP, et al. Photopheresis in the management of bronchiolitis obliterans syndrome (BOS) following lung transplantation [abstract]. Am J Respir Crit Care Med 1997; 155:A276
187. Valentine VG, Robbins RC, Wehner JH, et al. Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts. Chest 1996; 109:1184-1189
188. Pham SM, Keenan RJ, Rao AS, et al. Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann Thorac Surg 1995; 60:1015-1020
189. Pham SM, Zeevi A, Rao A, et al. Three year experience of combined donor bone marrow infusion and thoracic organ transplantation [abstract]. J Heart Lung Transplant 1997; 16:A69
190. Novick RJ, Schafers HJ, Stitt L, et al. Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients. J Thorac Cardiovasc Surg 1995; 110:1402-1413
191. Raisanen-Sokolowski A, Aho P, Tufveson G, et al. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants. Transplant Proc 1994; 26:3224
192. Gregory CR, Huie P, Billingham ME, et al. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury: its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation 1993; 55:1409-1418